by GlobeNewsWire | Jun 28, 2016 | Globe Newswire
NEW YORK, June 28, 2016 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today announced that, following communication with the...
by GlobeNewsWire | Jun 28, 2016 | Globe Newswire
MORRIS PLAINS, N.J., June 28, 2016 (GLOBE NEWSWIRE) — Immunomedics, Inc., (Nasdaq:IMMU) today announced the issuance of U.S. Patent 9,375,489, entitled “Antibody-SN-38 Immunoconjugates with a CL2A Linker.” This is the 28th issued U.S. patent covering the...
by GlobeNewsWire | Jun 28, 2016 | Globe Newswire
San Francisco, June 28, 2016 (GLOBE NEWSWIRE) — The global transfection reagent & equipment market is expected to reach USD 1,086.02 million by 2022, according to a new report by Grand View Research, Inc. This anticipated growth in demand can be attributed...
by GlobeNewsWire | Jun 27, 2016 | Globe Newswire
REDWOOD CITY, Calif., June 27, 2016 (GLOBE NEWSWIRE) — Relypsa, Inc. (NASDAQ:RLYP), a biopharmaceutical company, today announced that results of a pre-specified exploratory analysis of the Phase 3 OPAL-HK trial of Veltassa® (patiromer) for oral suspension were...
by GlobeNewsWire | Jun 27, 2016 | Globe Newswire
BOSTON, June 27, 2016 (GLOBE NEWSWIRE) — ZIOPHARM Oncology, Inc. (Nasdaq:ZIOP), a biopharmaceutical company focused on new cancer immunotherapies, today announced the successful completion of enrollment in the first and second dosing cohorts as well as the...